Objective In utero fetal surgery to correct incomplete closure of the spinal cord lessens the extent of permanent damage but is associated with preterm prelabour rupture of membranes (PPROM). We determined whether compounds in amniotic fluid collected at the time of surgery predicted subsequent development of PPROM.
gender between women with or without PPROM. Length of surgery, days of wound healing and length of hospital stay were also indistinguishable. The median concentrations of MMP-8 (1.7 versus 0.6 ng/ml; P = 0.0041) and lactic acid (7.1 versus 5.9 mM; P = 0.0181) were higher in women with PPROM. The amniotic fluid MMP-8 level was also negatively correlated with gestational age at delivery (Spearman r = À0.4217, P = 0.0319).
Conclusion Differences in susceptibility to develop PPROM are present before fetal surgery. An increase in anaerobic glycolysis, evidenced by the intra-amniotic lactic acid level, may enhance MMP-8 production and weaken maternal and fetal membranes.
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Introduction
Myelomeningocele (MMC) is one of the most common open neural tube defects that result from exposure of the spinal cord to the external environment. Its incidence in the USA is between 0.5 and 1.0/1000 live births;
1 the incidence in Brazil has been estimated as 1.9/1000 live births. 2 There is an initial failure of neurulation at about 28 days of gestation followed by protrusion of the meninges and spinal cord through open vertebral arches. Progressive neurological damage primarily occurs during the later stages of pregnancy due to exposure to as yet unidentified compounds in amniotic fluid, increased hydrodynamic pressure and physical trauma. 3 The effects of MMC include Chiari II malformation, hydrocephalus, paraparesis or paraplegia, and neuropathic bladder and rectum, as well as a range of endocrinological, orthopaedic, intellectual and psychosocial problems.
Findings from animal models of MMC as well as from studies of aborted human fetuses strongly suggest that the early defect of neurulation does not result in profound permanent long-term damage, due most likely to the plasticity of the fetal nervous system. [4] [5] [6] A subsequent multicentre trial, The Management of Myelomeningocele Study (MOMS), established that in utero surgery to repair the initial defect resulted in superior benefits for the baby at 1 and 2.5 years of age compared with postponing the surgery until after delivery. 7 There was a reduced rate of hindbrain herniation, severe herniation, placement of a shunt and inability to walk independently as well as improved results on numerous tests performed at age 2.5 years. This therapeutic success has led to the expansion of medical centres in the USA, Europe and South America that perform this operation. The primary site in South America that performs in utero surgery for MMC is in Sao Paulo, Brazil. 8, 9 This site is currently the institution with the second largest case series in the world for intrauterine repair of MMC. 9 However, there are complications unique to performing MMC repair surgery in utero. As noted in the MOMS study, 7 there was a 46% prevalence of spontaneous fetal membrane rupture and a 79% prevalence of preterm birth. It is unclear whether all women undergoing fetal surgery for MMC or other types of spina bifida are at similar risk for preterm prelabour rupture of membranes (PPROM) as a consequence of the surgical procedure or whether factors present in individual women at the time of surgery initiation influence susceptibility to this adverse event. In this pilot investigation, we evaluated whether compounds in amniotic fluid prospectively collected at the initiation of corrective surgery for spinal defects in Sao Paulo, Brazil, predicted subsequent development of PPROM.
Methods

Participants
The sample in this pilot study consisted of 24 consecutive cases of women carrying a singleton fetus with a spinal defect, as determined by ultrasound examination and magnetic resonance imaging. Eighteen of the women had a fetus with an MMC and six fetuses were diagnosed with rachischisis. The obstetric surgical procedure was similar for all participants, and the precise technique was as reported previously. 8, 9 All women received the same combination of general and intradural anaesthesia followed by magnesium sulphate, terbutaline and nifedipine for tocolysis. All received the same antibiotic -2 g intravenous cephazolin -before anaesthesia. None received steroids before surgery. The study was funded solely by institutional funds, and all women provided informed written consent. There was no participant or public involvement in the study.
Amniotic fluid analysis
Amniotic fluid was aseptically obtained with a sterile syringe at the beginning of the surgical procedure following opening of the uterus. As a replacement, all were given warmed saline solution at 37°C at a volume sufficient to surround the baby -about 200 ml. The protocol excluded external blood contamination. The clear fluid, about 20 ml, was frozen at À20°C until shipped as a single batch on dry ice to Weill Cornell (New York, NY, USA). All samples arrived frozen in excellent condition. They were thawed, subjected to centrifugation and the soluble fraction was stored in aliquots at À80°C. The particulate fraction was also similarly frozen for possible subsequent use.
Aliquots were thawed, kept in ice-water and assayed for concentrations of L-lactic acid (BioAssay Systems, Hayward, CA, USA), interleukin-6 (IL-6) (R&D Systems, Minneapolis, MN, USA) and three different metalloproteinase (MMP) enzymes -MMP-2, MMP-8 and MMP-9 (R&D Systems). Intra-and inter-assay variability was < 10%. The lower level of sensitivity was 9 pg/ml for IL-6, 0.3 ng/ml for MMP-2, 62.5 pg/ml for MMP-8, 31.3 pg/ml for MMP-9 and 0.2 mM for lactic acid. All testing was performed by personnel blinded to all clinical data. Pregnancy outcomes were ascertained from participants' charts only after completion of all laboratory studies.
Statistics
Differences between amniotic fluid concentrations of each compound between women with or without PPROM were analysed by the nonparametric Mann-Whitney U-test because the values did not follow a normal distribution. Differences in demographic variables between women with or without PPROM were assessed by Fisher's exact test. The correlation between the concentration of each compound and gestational age at delivery was assessed by the Spearman rank correlation test. A P value < 0.05 was considered significant.
Results
Characteristics of the study participants who did or did not experience PPROM are shown in Table 1 . There were no significant differences in maternal age, gravidity, parity, prior caesarean sections, smoking history or fetal gender between the two groups. Although the percentage of women who were white was higher in the group without PPROM, this did not reach statistical significance (P = 0.0593). None of the babies had any other congenital malformations.
Surgical variables in both groups are detailed in Table 2 . No significant differences in any surgical parameters were identified. Gestational age at surgery was 24.6 (AE0.9) weeks in the PPROM group and 25.4 (AE0.7) weeks in the controls. The mean length of surgery (127 versus 130 minutes), time for wound healing (7.3 versus 7.2 days) and length of hospital stay (6.9 versus 7.4 days) were similar in women with or without PPROM, respectively. There were no significant differences between groups in the percentage of women having a baby with MMC or rachischisis. All cases of PPROM occurred after 32 weeks of gestation. Table 3 lists the intra-amniotic concentration of the compounds measured in the two groups. The median level of MMP-8 was 1.7 ng/ml in women who subsequently experienced PPROM versus 0.6 ng/ml in the other women (P = 0.0005). In contrast, median concentrations of MMP-2 and MMP-9 were similar in both groups (P > 0.05). The median level of IL-6 was also indistinguishable between the groups. However, the median concentration of lactic acid was elevated in the PPROM group (7.1 versus 5.5 mM) (P = 0.0020). There were no differences in the concentration of any compound between the two different types of fetal anomalies. There were no associations between the interval from sample collection to analysis and concentration of any of the compounds analysed, indicating that there was no influence of storage time on the detected values.
The higher the MMP-8 concentration, the lower was the gestational age at delivery (Spearman r = À0.4375, P = 0.0325). A similar negative correlation between the lactic acid concentration and gestational age at delivery approached but did not reach statistical significance (Spearman r = À0.3069, P = 0.1440). There were no associations between MMP-2, MMP-9 and IL-6 levels and gestational age at delivery.
Discussion
Main findings
Based on our pilot study, it appears that elevated intraamniotic concentrations of MMP-8 and lactic acid at the time of in utero fetal surgery for a spinal defect identify a group of women with increased susceptibility to subsequently develop PPROM. These observations strongly suggest that individual variations between women and/or their fetuses in their response to an open spinal defect influence the strength of the maternal and fetal membranes. Women with a weakened membrane would then be more likely to experience a membrane rupture following intrauterine surgery. The rate of PPROM in MMC cases in which surgery is delayed until after birth has been reported to be only 8%. 7 This indicates that most likely it is the combination of a predisposing intra-amniotic elevation in MMP-8, and possibly additional compounds, plus the in utero surgical intervention that is responsible for increasing the risk of PPROM.
Strengths and limitations
The major limitation of this study is the small number of women who were evaluated. As the numbers were low, the results should be seen as hypothesis testing and further analysis of a larger number of women undergoing this surgical procedure is needed to confirm the present findings. However, these initial observations are consistent with data from other systems and, coupled with potentially high clinical and scientific relevance, their dissemination should be an impetus to encourage future investigations in this area. In addition, as the study only evaluated women in Brazil investigations of women in other countries will be necessary to determine whether the findings can be generalised to different populations. Identification of women at elevated risk of PPROM following in utero surgery will lead to more focused monitoring and intervention in this subgroup. Long-term follow up of neonates who underwent fetal surgery will also allow determination of whether the intra-amniotic lactic acid and MMP-8 levels are potential indicators of postnatal developmental events.
Although the difference did not reach statistical significance, the findings suggest that non-white race may be a variable associated with development of PPROM after fetal surgery. The small number of women in our study precludes making any conclusions from this observation. Among pregnant women seen in our racially heterogeneous Brazilian population who do not undergo this surgery, there is no association between non-white race and PPROM (unpublished observation).
The major strengths of the study are its prospective design, use of the same experienced surgical team and identical pre-, peri-and post-treatment protocols for all participants.
Interpretation
Our observed association between MMP-8 and PPROM is consistent with previous reports of a similar association in women who have not undergone intrauterine surgery. 10, 11 In those cases, it was believed that an increased MMP-8 level was a consequence of infection-induced inflammation; elevated concentrations of the pro-inflammatory cytokine, IL-6, 10-12 reinforced this putative mechanism. In contrast, in our study there were no associations between IL-6 levels and either MMP-8, lactic acid or PPROM. This suggests that infection/inflammation-related compounds were most likely not the inducers of MMP-8 in fetuses with spina bifida.
The observed association between MMP-8 and lactic acid levels suggests that hypoxic conditions are elevated in the amniotic cavity as a consequence of an open spinal defect. Lactic acid, the major by-product of glycogen metabolism in an anaerobic environment, has been shown to be present at elevated levels in amniotic fluid 13 as well as in spinal fluid 14 from fetuses with spina bifida compared with fetuses with normal neurological development. There is a precedent for an elevation in MMP production under hypoxic conditions. MMP-1, a member of the MMP-8 subgroup with collagenase activity, has been shown to increase in a number of oncogenic cell lines following induction of hypoxia. 15 MMP-1 was not evaluated in this study. The variable extent to which hypoxia is elevated in individual cases, due a variety of maternal and/or fetal factors, may explain the differences in susceptibility to develop PPROM after fetal surgery.
Conclusion
Susceptibility to develop PPROM following in utero fetal surgery may be related to differences in variables between individual women and/or their fetuses that are already present before the surgical intervention. It will be of interest to determine whether the amniotic fluid levels of lactic acid are predictive of the extent of hypoxia and susceptibility to PPROM or preterm birth in women who do not undergo a surgical intervention.
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